These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19038965)

  • 1. SB366791, a TRPV1 antagonist, potentiates analgesic effects of systemic morphine in a murine model of bone cancer pain.
    Niiyama Y; Kawamata T; Yamamoto J; Furuse S; Namiki A
    Br J Anaesth; 2009 Feb; 102(2):251-8. PubMed ID: 19038965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease-activated receptor 2 antagonist potentiates analgesic effects of systemic morphine in a rat model of bone cancer pain.
    Bao Y; Hou W; Yang L; Kong X; Du M; Zheng H; Gao Y; Hua B
    Reg Anesth Pain Med; 2015; 40(2):158-65. PubMed ID: 25650631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic antinociceptive effect of a calcium channel blocker and a TRPV1 blocker in an acute pain model in mice.
    Palhares MR; Silva JF; Rezende MJS; Santos DC; Silva-Junior CA; Borges MH; Ferreira J; Gomez MV; Castro-Junior CJ
    Life Sci; 2017 Aug; 182():122-128. PubMed ID: 28629730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the opioids fentanyl and morphine on nociception and bone destruction in a murine model of bone cancer pain.
    El Mouedden M; Meert TF
    Pharmacol Biochem Behav; 2007 May; 87(1):30-40. PubMed ID: 17521715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic effects of nonsteroidal antiinflammatory drugs, acetaminophen, and morphine in a mouse model of bone cancer pain.
    Saito O; Aoe T; Yamamoto T
    J Anesth; 2005; 19(3):218-24. PubMed ID: 16032450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioids and TRPV1 in the peripheral control of neuropathic pain--Defining a target site in the injured nerve.
    Labuz D; Spahn V; Celik MÖ; Machelska H
    Neuropharmacology; 2016 Feb; 101():330-40. PubMed ID: 26453963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of opiate-mediated behaviors by the selective TRPV1 antagonist SB366791.
    Ma SX; Kwon SH; Seo JY; Hwang JY; Hong SI; Kim HC; Lee SY; Jang CG
    Addict Biol; 2017 Nov; 22(6):1817-1828. PubMed ID: 27730727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons.
    Niiyama Y; Kawamata T; Yamamoto J; Omote K; Namiki A
    Neuroscience; 2007 Aug; 148(2):560-72. PubMed ID: 17656027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRPV1 modulates morphine-induced conditioned place preference via p38 MAPK in the nucleus accumbens.
    Hong SI; Nguyen TL; Ma SX; Kim HC; Lee SY; Jang CG
    Behav Brain Res; 2017 Sep; 334():26-33. PubMed ID: 28734766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic QX-314 Reduces Bone Cancer Pain through Selective Inhibition of Transient Receptor Potential Vanilloid Subfamily 1-expressing Primary Afferents in Mice.
    Fuseya S; Yamamoto K; Minemura H; Yamaori S; Kawamata T; Kawamata M
    Anesthesiology; 2016 Jul; 125(1):204-18. PubMed ID: 27176211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pain-related behavior, bone destruction and effectiveness of fentanyl, sufentanil, and morphine in a murine model of cancer pain.
    El Mouedden M; Meert TF
    Pharmacol Biochem Behav; 2005 Sep; 82(1):109-19. PubMed ID: 16125759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of mu opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murine model of bone cancer pain.
    Yamamoto J; Kawamata T; Niiyama Y; Omote K; Namiki A
    Neuroscience; 2008 Feb; 151(3):843-53. PubMed ID: 18178319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic effects of a soy-containing diet in three murine bone cancer pain models.
    Zhao C; Wacnik PW; Tall JM; Johns DC; Wilcox GL; Meyer RA; Raja SN
    J Pain; 2004 Mar; 5(2):104-10. PubMed ID: 15042518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats.
    Adamczyk P; Miszkiel J; McCreary AC; Filip M; Papp M; Przegaliński E
    Brain Res; 2012 Mar; 1444():45-54. PubMed ID: 22325096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte activation in a mouse model.
    Ren BX; Gu XP; Zheng YG; Liu CL; Wang D; Sun YE; Ma ZL
    Anesthesiology; 2012 Jan; 116(1):122-32. PubMed ID: 22123524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-administration of transient receptor potential vanilloid 4 (TRPV4) and TRPV1 antagonists potentiate the effect of each drug in a rat model of cystitis.
    Charrua A; Cruz CD; Jansen D; Rozenberg B; Heesakkers J; Cruz F
    BJU Int; 2015 Mar; 115(3):452-60. PubMed ID: 25041193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia.
    Honore P; Chandran P; Hernandez G; Gauvin DM; Mikusa JP; Zhong C; Joshi SK; Ghilardi JR; Sevcik MA; Fryer RM; Segreti JA; Banfor PN; Marsh K; Neelands T; Bayburt E; Daanen JF; Gomtsyan A; Lee CH; Kort ME; Reilly RM; Surowy CS; Kym PR; Mantyh PW; Sullivan JP; Jarvis MF; Faltynek CR
    Pain; 2009 Mar; 142(1-2):27-35. PubMed ID: 19135797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat.
    Varga A; Németh J; Szabó A; McDougall JJ; Zhang C; Elekes K; Pintér E; Szolcsányi J; Helyes Z
    Neurosci Lett; 2005 Sep; 385(2):137-42. PubMed ID: 15950380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of capsazepine, a transient receptor potential vanilloid type 1 antagonist, on morphine-induced antinociception, tolerance, and dependence in mice.
    Nguyen TL; Nam YS; Lee SY; Kim HC; Jang CG
    Br J Anaesth; 2010 Nov; 105(5):668-74. PubMed ID: 20719804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive and genotoxic assessments of the antagonist TRPV1 receptor SB-366791 on morphine-induced tolerance in mice.
    Mazeto TK; Picada JN; Correa ÁP; Rebelo IN; Ribeiro MT; Gomez MV; de Souza AH
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Mar; 393(3):481-490. PubMed ID: 31655852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.